Scientifically Formulated Nootropic Backed by 2025 Research for Sharper Focus and Cognitive Support. Scientifically Formulated Nootropic Backed by 2025 Research for Sharper Focus and Cognitive Support ... .
SOLANA BEACH, CA / ACCESSNewswire / August 12, 2025 / ClearPoint Neuro, Inc ... About ClearPoint Neuro. ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine ... CLEARPOINT NEURO, INC.
ClearPoint Neuro Reports SecondQuarter 2025 Results... SOLANA BEACH, CA, August 12, 2025 - ClearPoint Neuro, Inc ... About ClearPoint Neuro ... The Company's flagship product, the ClearPoint Neuro NavigationSystem, has FDA clearance and is CE-marked.
In 2022, we commercialized the ClearPoint Prism Neuro LaserTherapySystem as our first therapy product offering. We have exclusive global commercialization rights to the ClearPoint Prism Neuro Laser Therapy System through our Swedish partner, CLS.
The global stereotactic neuro-navigation system market is anticipated to experience significant growth, escalating from a valuation of $840.7 million in 2024 to $3.10 billion by 2035, with a CAGR of 12.92%.
SOLANA BEACH, CALIFORNIA / ACCESSNewswire / August 4, 2025 / ClearPoint Neuro, Inc ... The SmartFlow® Neuro Cannula is the only FDA authorized device indicated for use to administer KEBILIDI ... About the SmartFlow Neuro Cannula ... About ClearPoint Neuro.